<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Proteome Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Proteome Res</journal-id>
    <journal-id journal-id-type="publisher-id">pr</journal-id>
    <journal-id journal-id-type="coden">jprobs</journal-id>
    <journal-title-group>
      <journal-title>Journal of Proteome Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1535-3893</issn>
    <issn pub-type="epub">1535-3907</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9904285</article-id>
    <article-id pub-id-type="pmid">35759515</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jproteome.2c00048</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>urPTMdb/TeaProt:
Upstream and Downstream Proteomics
Analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6575-504X</contrib-id>
        <name>
          <surname>Molendijk</surname>
          <given-names>Jeffrey</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6697-2270</contrib-id>
        <name>
          <surname>Yip</surname>
          <given-names>Rui</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1818-2183</contrib-id>
        <name>
          <surname>Parker</surname>
          <given-names>Benjamin L.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Department
of Anatomy and Physiology, <institution>University of
Melbourne</institution>, Melbourne, VIC 3010, <country>Australia</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>jeff.molendijk@unimelb.edu.au</email>. Phone: <phone>+61 401 758 489</phone>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>27</day>
      <month>06</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>03</day>
      <month>02</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>27</day>
      <month>06</month>
      <year>2023</year>
    </pub-date>
    <volume>22</volume>
    <issue>2</issue>
    <issue-title>Software Tools and Resources
2023</issue-title>
    <fpage>302</fpage>
    <lpage>310</lpage>
    <history/>
    <permissions>
      <copyright-statement>© 2022 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_0005" id="ab-tgr1"/>
      </p>
      <p>We have developed
the underrepresented post-translational modification
(PTM) database (urPTMdb), a PTM gene set database to accelerate the
discovery of enriched protein modifications in experimental data.
urPTMdb provides curated lists of proteins reported to be substrates
of underrepresented modifications. Their enrichment in proteomics
datasets can reveal unexpected PTM regulations. urPTMdb can be implemented
in existing workflows, or used in TeaProt, an online Shiny tool that
integrates upstream transcription factor enrichment analysis with
downstream pathway analysis through an easy-to-use interactive interface.
TeaProt annotates user-uploaded data with drug–gene interactions,
subcellular localizations, phenotypic functions, gene–disease
associations, and enzyme–gene interactions. TeaProt enables
gene set enrichment analysis (GSEA) to discover enrichments in gene
sets from various resources, including MSigDB, CHEA, and urPTMdb.
We demonstrate the utility of urPTMdb and TeaProt through the analysis
of a previously published Western diet-induced remodeling of the tongue
proteome, which revealed altered cellular processes associated with
energy metabolism, interferon alpha/gamma response, adipogenesis,
HMGylation substrate enrichment, and transcription regulation through
PPARG and CEBPA. Additionally, we analyzed the interactome of ADP-ribose
glycohydrolase TARG1, a key enzyme that removes mono-ADP-ribosylation.
This analysis identified an enrichment of ADP-ribosylation, ribosomal
proteins, and proteins localized in the nucleoli and endoplasmic reticulum.
TeaProt and urPTMdb are accessible at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tea.coffeeprot.com/">https://tea.coffeeprot.com/</uri>.</p>
    </abstract>
    <kwd-group>
      <kwd>proteomics</kwd>
      <kwd>PTM</kwd>
      <kwd>database</kwd>
      <kwd>software</kwd>
      <kwd>bioinformatics</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>National Health and Medical Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000925</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>APP1184363</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>University of Melbourne</institution>
            <institution-id institution-id-type="doi">10.13039/501100001782</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>pr2c00048</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>pr2c00048</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>The field of omics-based
research has expanded tremendously due
to advances in instrumentation, leading to the generation of increasing
amounts of experimental data. Concurrently, advances in bioinformatics
tools and databases have been essential in allowing the discovery
of biological insights into diseases and experimental treatments.
The introduction of the gene set enrichment analysis (GSEA)<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> allowed the widespread discovery of biologically
relevant enrichment patterns in differential expression data, by comparing
experimental data with predefined lists of targets known as gene sets.
Collections of gene sets have been defined for biological pathways,
genomic location, subcellular localization, interactions with transcription
factors, and associations with tissues or diseases. Furthermore, this
type of analysis is not limited to gene sets, but has been expanded
to include phosphosite-specific signatures<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> and lipid sets.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> This flexibility with
regards to the input gene set collection has led to the implementation
of GSEA in numerous tools and packages, leading to over 31 000
citations of the original publication by Subramanian et al.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Maleki et al. provide an in-depth review of gene
set analysis methods, list over 100 available tools, explain the different
methods and significance assessments commonly used, and discuss the
shortcomings of each approach.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Surprisingly,
collections of gene sets related to post-translational modifications
(PTMs) are limited, despite the significant biological impacts of
these modifications. Although gene set databases for some PTMs such
as phosphorylation have been created,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> for
many PTMs discovered in recent years such gene sets are nonexistent.
Furthermore, gene sets related to PTMs can be divided in those that
contain the pathway enzymes versus gene sets that contain the PTM
substrates. The former category (PTM pathway gene sets) contains a
handful of known enzymes involved in the synthesis, conjugation, and
catabolism of the modifying molecule. The latter category (PTM substrates)
can contain hundreds of proteins known to receive a specific PTM,
typically derived from experimental proteomics data.</p>
    <p>A recent
publication has highlighted the capabilities of mass spectrometry-based
proteomics techniques to characterize a wide array of PTMs,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> many of which are exciting modifications with
undiscovered roles in biological processes. As evidenced by PubMed
query trends, various novel PTMs have been discovered in recent years,
the functions and associations of which are only just starting to
be studied (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). For example, poly-ADP-ribosylation was found to prevent proteasomal
degradation of proteins by inducing deubiquitylation,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and lysine lactoylation is enriched on glycolytic enzymes,
suggesting a role in the regulation of glycolysis.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> To accommodate future research into these exciting modifications,
we generated 153 gene sets for 18 PTMs (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). Our novel underrepresented PTM database,
urPTMdb, was developed to accelerate ongoing and future research,
as disease or experimental treatment associated with these PTMs may
not be discovered if the analysis software does not take them into
account. urPTMdb is freely available to be downloaded for use in commonly
used GSEA workflows or can directly be used in our novel tool TeaProt.
TeaProt is a novel tool suited for the functional analysis and integration
of proteomics/transcriptomics data on the results of differential
expression analyses (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). The TeaProt workflow is primarily focused on data annotation,
functional enrichment, and gene set enrichment analyses based on curated
pathways, transcription factors, and post-translational modifications.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Underrepresented
PTMs. (A) PubMed publications per year discussing
underrepresented PTMs. (B) Overview of urPTMdb. (C) Number of gene
sets per PTM included in urPTMdb. (D) Gene set Jaccard index network
of urPTMdb. The Jaccard index indicates the similarity between two
gene sets, where the connected nodes have an index &gt;0.15.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_0001" id="gr1" position="float"/>
    </fig>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Overview of the TeaProt workflow. Differential expression
results
from external tools are entered and validated. Input data are pre-processed
and annotated using information on subcellular localizations, transcription
factors, and interactions with other molecules. Analyses are divided
into quality control and enrichment analyses. The distribution of <italic>p</italic>-values or fold-changes (1) can be inspected prior to the
other analyses. Volcano plots aid the identification of proteins that
are differentially expressed (2). The annotated data are visualized
in contingency tables to highlight enriched groups of proteins/transcripts
present in the data (3). The gene set enrichment analyses include
analyses based on MSigDB (4), CHEA (5), and the novel underrepresented
PTM database, urPTMdb (6).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_0002" id="gr2" position="float"/>
    </fig>
    <p>In some cases, the novelty of an analytical tool is not defined
by the methods it uses, but by the annotations or underlying databases
that were previously unavailable. For example, despite the widespread
use of overrepresentation and gene set enrichment analyses in other
tools, CHEA3<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> enabled transcription factor
enrichment analyses (TFEA) by combining public data from various sources
(ChIP-seq, coexpression, literature) and thus generating a comprehensive
novel resource. Evidently, the value of a tool depends not only on
the analyses that it can perform, but also on advances in the databases
that allow the discovery of biological alterations that could otherwise
not be detected. To this end, urPTMdb combines proteomics search results
and summarizes public proteomics-based data of underrepresented PTMs
into a novel resource that is freely available and can be expanded
as additional primary data are published.</p>
  </sec>
  <sec id="sec2">
    <title>Methods</title>
    <sec id="sec2.1">
      <title>PubMed Query
Analysis</title>
      <p>To identify the number of publications
published per year, mentioning underrepresented PTMs of interest,
we performed PubMed queries using the following terms: (lysine &amp;
Kac) | “lysine acetylation”, ADP-ribosylation, AMPylation,
“citrullination”, (lysine &amp; Kcr) | “lysine
crotonylation”, “DSSylation”, “FAT10ylation”,
(lysine &amp; Kglu) | “lysine glutarylation”, “HMGylation”,
(lysine &amp; Khib) | “lysine hydroxyisobutyrylation”
| “lysine 2-hydroxyisobutyrylation”, “ISGylation”,
(lysine &amp; lactoylation) | lactoyllys, “protein lipidation”
| “peptide lipidation”, (lipoylation &amp; protein),
“neddylation”, (prolyl &amp; hydroxylation) | (proline
&amp; hydroxylation), (lysine &amp; Ksu) | “lysine succinylation”,
“UFMylation”. The resulting “results by year”
graphs displayed by PubMed were downloaded and combined into a single
graph. For <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A, data points between 2007–2021 were displayed.</p>
    </sec>
    <sec id="sec2.2">
      <title>urPTMdb</title>
      <p>urPTMdb is a novel database of gene sets covering
currently underrepresented PTMs. A total of 18 PTMs were selected
on the basis of their presence in proteomic data repositories, whilst
being underrepresented in gene set databases. Specifically, we generated
gene sets for proteins modified by adenosine diphosphate ribose (ADP-ribosylation),
covalently attached adenosine monophosphate (AMPylation), citrullination,
deleted in split hand/split foot 1 (DSS1) conjugation (DSSylation),
Human Leukocyte Antigen (HLA)-F adjacent transcript 10 (FAT10) conjugation
(FAT10ylation), 3-hydroxyl-3-methylglutarylation (HMGylation), interferon
stimulated gene 15 (ISG15) conjugation (ISGylation), lipidation (myristoylation
and prenylation), lipoylation, lysine acetylation (Kac), lysine crotonylation
(Kcr), lysine glutarylation (Kglu), lysine 2-hydroxyisobutyrylation
(Khib), lysine lactoylation (LactoylLys), lysine succinylation (Ksu),
neuronal precursor cell-expressed developmentally down-regulated protein
8 (NEDD8) conjugation (neddylation), prolyl hydroxylation and Ubiquitin-fold
modifier 1 (UFM1) conjugation (UFMylation) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). These PTMs were selected because of being
currently understudied (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A), an absence of relevant gene sets in existing gene set
collections, and the availability of experimental proteomics data.
Datasets related to the PTMs were collected from the Proteomics Identifications
Database (PRIDE)<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> and Mass Spectrometry
Interactive Virtual Environment (MASSIVE). The collected datasets
are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_002.xlsx">Supplementary Table S1</ext-link>. Datasets
were processed in R, and the scripts to generate the gene sets have
been deposited to <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.github.com/JeffreyMolendijk/urPTMdb">www.github.com/JeffreyMolendijk/urPTMdb</uri>. Additionally, literature/pathway gene sets were manually created
on the basis of the known enzymes involved in each modification or
retrieved from MSigDB.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> These gene sets
were collated into a collection (urptmdb_latest.gmt) that is included
for direct use in TeaProt or available to be downloaded from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tea.coffeeprot.com/">https://tea.coffeeprot.com/</uri> and <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.github.com/JeffreyMolendijk/urPTMdb">www.github.com/JeffreyMolendijk/urPTMdb</uri>. The urPTMdb file follows the conventions of the “gene matrix
transposed file format” (.gmt) that is commonly used to store
collections of gene sets. Following this format we report the gene
set names in the first column, a description in the second column,
and the relevant genes in all subsequent columns. Furthermore, species-specific
human or mouse versions of urPTMdb were generated by converting gene
symbols to their respective homologues using HomoloGene. Note that
these databases still contain gene sets annotated with either “hs”
or “mm” to indicate the species in which the experiments
were performed, but the reported gene symbols are species-specific.
Generating a network of gene sets, where nodes are connected on the
basis of the Jaccard index (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D), indicates that gene sets of the same PTM, or of
a similar type (e.g., ubiquitin-like modifiers), have significant
overlap in the included proteins. A drawback of the Jaccard index
is a failure to visualize similar gene sets with large differences
in the number of genes contained in each set. Upon inspection of the
lone citrullination gene set (PXD026238_mm_Citrullination_sites),
it appears that the difference in size is cause for the low Jaccard
index with other citrullination gene sets. On the basis of this finding
we decided to generate another plot based on the Szymkiewicz–Simpson
coefficient rather than the Jaccard index. The Jaccard index is calculated
as the ratio of the intersection and the union of the two sets, whereas
the Szymkiewicz–Simpson coefficient is the ratio of the intersection
and the number of genes in the smaller gene set. A small gene set
that is completely present in a larger second gene set is expected
to get a low Jaccard index, but a high Szymkiewicz–Simpson
coefficient. The gene set that was previously isolated (PXD026238_mm_Citrullination_sites)
is connected to five other citrullination gene sets with a Szymkiewicz–Simpson
coefficient ≥0.6. Interactive Jaccard and Szymkiewicz–Simpson
networks can be inspected on the urPTMdb tab of the TeaProt web server.</p>
    </sec>
    <sec id="sec2.3">
      <title>TeaProt</title>
      <sec id="sec2.3.1">
        <title>Web Server Implementation</title>
        <p>TeaProt is implemented as
a Shiny application using the R programming language for the backend.
TeaProt is deployed on the Nectar Research Cloud and Melbourne Research
Cloud, utilizing hypervisors built on AMD EPYC 2 (base CPU clock speed
2.0 GHz, burst clock speed 3.35 GHz) and running Ubuntu 18.04.</p>
      </sec>
      <sec id="sec2.3.2">
        <title>Privacy
and Security</title>
        <p>Any uploaded tables are only available
to be analyzed if the user is connected to the TeaProt server. No
user data are retained following session termination. Secure HTTPS
connections are used to transfer data to and from the TeaProt server.</p>
      </sec>
      <sec id="sec2.3.3">
        <title>Local Installation</title>
        <p>The code required to run TeaProt
is hosted at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.github.com/ryip10903/TeaProt">www.github.com/ryip10903/TeaProt</uri>. Creating a copy of the TeaProt allows users to run the application
locally, without accessing the web server. After installing the R
packages required by TeaProt, users can directly launch the Shiny
application to start analyzing their own data.</p>
      </sec>
      <sec id="sec2.3.4">
        <title>Databases
and Packages</title>
        <p>TeaProt converts UniProt and
ENSEMBL identifiers to gene symbols using the AnnotationDbi package
in combination with the org.Hs.eg.db (human, version 3.14.0) and org.Mm.eg.db
(mouse, version 3.14.0) packages. Subcellular localizations were retrieved
from the Cell Atlas<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> and were further
annotated with ancestor localizations to reduce overly specific localizations.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Genotype–phenotype associations were
downloaded from the International Mouse Phenotyping Consortium (IMPC, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.mousephenotype.org">www.mousephenotype.org</uri>).<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Transcription factor data were downloaded from
CHEA3.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Gene-disease associations were
retrieved from DisGeNet (v7)<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> and gene-enzyme
annotations from BRENDA (BRENDA is available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.brenda-enzymes.org">www.brenda-enzymes.org</uri>).<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Drug–gene interactions were retrieved
from the drug–gene interaction database (DGIdb).<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Gene set enrichment analyses are performed using
the fgsea package (version 1.20.0).<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></p>
      </sec>
      <sec id="sec2.3.5">
        <title>Documentation and Tutorial</title>
        <p>A demo dataset of Western
diet-induced remodeling of the tongue proteome is included with TeaProt.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> This dataset and a detailed tutorial are available
on the “start” page of TeaProt.</p>
      </sec>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results and Discussion</title>
    <sec id="sec3.1">
      <title>Case Study
1: Analyzing Tongue Proteomics Data Using TeaProt</title>
      <p>To illustrate
the use of TeaProt, we re-analyzed a previously published
dataset of the alterations in the tongue proteome induced by the Western
diet enriched in carbohydrates and lipids including cholesterol.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> The differential expression results obtained
by comparing the control diet with the Western diet were used in this
case study and are also available as a demo dataset in TeaProt. The
first step in the workflow involves validating the user-uploaded data
and performing annotation based on the parameters set by the user.
The aforementioned parameters include the selection of the columns
corresponding to the gene identifier, <italic>p</italic>-value and
fold-change. Furthermore, the species which the data are generated
from and the <italic>p</italic>-value and fold-change significance
cutoffs need to be specified. TeaProt visualizes the distributions
of <italic>p</italic>-values and fold-changes in the uploaded data
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A,B) and generates
an interactive volcano plot to highlight the proteins with the greatest
changes between conditions (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C). Finally, the data are filtered and annotated with
databases.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tongue proteomics analysis. Tongue proteomics data from Dutt et
al. were prepared to analyze the differential expression results of
Western diet vs chow diet. Distributions of (A) <italic>p</italic>-values and (B) log<sub>2</sub> fold changes between treatment groups.
(C) Volcano plot highlighting proteins with an absolute log<sub>2</sub> fold change &gt;1 and <italic>p</italic> &lt; 0.05. (D) A Pearson’s
Chi-squared test based on protein annotations (subcellular localization)
indicates whether specific annotations are primarily found in significantly
(<italic>p</italic> &lt; 0.05) upregulated, downregulated, or nonsignificant
(NS) proteins. Only localizations with residuals &gt; 2 and &lt; −2
in the upregulated group are shown. The data in the figure are colored
by Pearson residuals and sized by the absolute Pearson residuals.
(E) GSEA using the MSigDB Hallmark collection reveals six significantly
enriched pathways (<italic>p</italic><sub>adj</sub> &lt; 0.05). (F)
GSEA using the CHEA3 Literature collection reveals two significantly
enriched gene sets (<italic>p</italic><sub>adj</sub> &lt; 0.05). (G)
GSEA enrichment and volcano (H) plots for the urPTMdb set “PXD005895_mm_HMGylation_substrates”.
Proteins found in the gene set are highlighted in the volcano plot.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_0003" id="gr3" position="float"/>
      </fig>
      <p>TeaProt currently supports annotations for <italic>Homo sapiens</italic> and <italic>Mus musculus</italic>. Data are
annotated with information
from the drug–gene interaction database,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Cell Atlas,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> IMPC,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> BRENDA,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and DisGeNet.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> The annotation tab visualizes the distribution
of annotations from various sources.</p>
      <p>The annotated data are
analyzed to detect enrichments in the upregulated
or downregulated protein targets, in accordance with user-defined
significance cutoffs. Cell Atlas annotations reveal whether the altered
proteins are found in specific organelles (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>D, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_003.xlsx">Supplementary Table S2</ext-link>), where the data points refer to the Pearson residuals (Residual
= (Observed – Expected)/Expected<sup>0.5</sup>) as derived
from a Chi-square test of independence. In this dataset, the proteins
upregulated as a result of the Western diet are enriched in proteins
localized in the mitochondria, consistent with the previously described
changes in energy metabolism induced by Western diets across a range
of tissues.<sup><xref ref-type="bibr" rid="ref18">18</xref>−<xref ref-type="bibr" rid="ref21">21</xref></sup></p>
      <p>TeaProt also enables easy gene set enrichment analysis using
gene
sets from various sources including the MSigDB<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> to characterize the downstream cellular process regulated, and the
transcription factor sets from CHEA3<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> to
characterize potential upstream transcriptional regulators. Performing
the GSEA analysis using the MSigDB Hallmark collection reveals six
significantly enriched gene sets related to interferons, oxidative
phosphorylation, fatty acid metabolism, adipogenesis, and androgen
response (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>E).
Furthermore, gene sets relating to the transcription factors Peroxisome
proliferator- activated receptor gamma (PPARG) and CCAAT/enhancer-binding
protein alpha (CEBPA) were significantly enriched in the dataset (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>F). Both PPARG and
CEBPA have previously been characterized to play important roles in
the metabolism of lipids, confirming the ability of TeaProt to identify
known up-stream regulators.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> Performing
GSEA using urPTMdb gene sets reveals an enrichment of HMGylation substrates
in the Western diet-fed mice, as the gene set with the lowest <italic>q</italic>-value (normalized enrichment score (NES): 2.25, adjusted <italic>p</italic>-value 1.1 × 10<sup>–8</sup>) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>G) followed by lysine glutarylation
(NES: 2.13, adjusted <italic>p</italic>-value 6.1 × 10<sup>–6</sup>) (data not shown). HMGylation is a fascinating nonenzymatic PTM
that has been validated in recent years by Wagner et al.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> HMGylation is similar to glutarylation with
significant overlap between the HMGylome and Glutarylome.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> The authors found that proteins involved in
ketogenesis and leucine degradation and the TCA cycle are among the
most HMGylated proteins, suggesting that the HMG-CoA generated in
these pathways reacts nonenzymatically and locally with nearby proteins.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> These findings support the previously described
enrichment of proteins related to oxidative phosphorylation and lipid
metabolism (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>E) and a related increase in protein HMGylation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>G). Generating a volcano plot
where the HMGylation gene set is highlighted indicates that the top
altered proteins are Aldob, Ech1, Cpt2, and Acadl (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>H). Altogether, these enrichment
results show consistent alterations in the tongue protein composition
associated with lipid metabolism. Furthermore, the analysis using
the urPTMdb generated a new hypothesis on the possible regulation
of HMGylation following consumption of Western diet.</p>
    </sec>
    <sec id="sec3.2">
      <title>Case Study
2: Using urPTMdb to Identify the Effects of Underrepresented
PTM Alterations</title>
      <p>The use of urPTMdb in GSEA allows the discovery
of proteome-wide PTM alterations induced by a specific intervention
or experimental design, by comparisons to published proteomics datasets.
Here we show an application of urPTMdb by analyzing the TARG1 tandem
affinity purification proteome in olaparib treated HEK293 cells.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> TARG1 is an ADP-ribose glycohydrolase that hydrolyzes
mono-ADP-ribose attached to protein glutamate residues. The ARTD1/2
inhibitor olaparib was added to reduce poly-ADP-ribose (PAR) formation
as a result of cell lysis-induced DNA shearing. We downloaded <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_003.xlsx">Supplementary Table S2</ext-link> to compare the TARG1-TAP
condition with the control TAP-tag condition using TeaProt and urPTMdb.
The downloaded data were reprocessed by filtering by number of missing
values (&lt;6), imputation, log<sub>2</sub> transforming the data,
and finally calculating the fold change and <italic>p</italic>-value
for each protein. In the TeaProt analyses, we considered a protein
with a log<sub>2</sub> fold change &gt;1 and <italic>p</italic>-value
&lt;0.05 to be significantly altered. Inspecting the distributions
of <italic>p</italic>-values and fold changes reveals a skewed distribution
with more positive fold changes than negative fold changes, which
is generally expected for the enrichment of proteins following affinity
purification (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A,B). Using these aforementioned criteria, 207 out of 1039 measured
proteins were increased in the TARG1-TAP condition (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C). As shown in the volcano
plot, the largest fold change (10 000×) was detected for
the protein TARG1.</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Underrepresented PTM GSEA. GSEA were performed on the
TARG1 tandem
affinity purification of olaparib treated HEK293 cells published by
Bütepage et al. Distributions of (A) <italic>p</italic>-values
and (B) log<sub>2</sub> fold changes between treatment groups. (C)
Volcano plot highlighting proteins with a log<sub>2</sub> fold change
&gt;1 and <italic>p</italic> &lt; 0.05. (D) A Pearson’s Chi-squared
test based on protein annotations (subcellular localization) indicates
whether specific annotations are primarily found in significantly
(<italic>p</italic> &lt; 0.05) upregulated, downregulated, or nonsignificant
(NS) proteins. Only localizations with positive residuals in the upregulated
group are shown. The data in the figure are colored by Pearson residuals
and sized by the absolute Pearson residuals. (E) GSEA using the urPTMdb
sets highlighting the top 5 significantly enriched pathways (<italic>p</italic><sub>adj</sub> &lt;0.05). (F) GSEA enrichment and volcano
(G) plots for the urPTMdb set “PXD028902_hs_ADPribosylation_substrates”.
Proteins found in the gene set are highlighted in the volcano plot.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_0004" id="gr4" position="float"/>
      </fig>
      <p>Approximately 86% of the uploaded proteins were
annotated with
one or more subcellular localizations. Inspection of the subcellular
localization contingency table reveals that a relatively large number
of up-regulated proteins are located in the endoplasmic reticulum
(16 expected, 42 detected) (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>D, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_004.xlsx">Supplementary Table S3</ext-link>). The number of expected annotations per group (upregulated, downregulated,
not significant) refers to the number of annotations we expect to
find in the absence of group enrichment, assuming the same proportion
of annotated proteins in each group. Out of these 42 upregulated endoplasmic
reticulum (ER) proteins, 38 are ribosomal proteins. Similarly, more
than the expected number of nucleolar proteins were found (17 expected,
37 detected) among the up-regulated proteins. These findings are in
agreement with those found by the authors and previous publications;
TARG1 was shown to be primarily located in the nucleoli and the ribosomal
proteins are the main interacting partners in the TARG1 interactome.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> ADP-ribosylation of ribosomal proteins is a key mechanism of inhibiting
polysome assembly though eIF6 binding to ribosomes.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> The authors note that mono-ADP-ribosylation of ribosomal
proteins promotes protein homeostasis by altering protein synthesis
and preventing toxic protein aggregation.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p>
      <p>The TARG1-interactome showed significant enrichment of proteins
with known ADP-ribosylation sites (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>E) where most ADP-ribosylation substrate
proteins are more abundant in the TARG1-TAP condition. The top five
most positively enriched PTM sets, when sorted by normalized enrichment
scores (NES), are all related to ADP-ribosylation and are consistent
with the results from multiple previous studies (PXD028902, PXD024233,
PXD020589). These findings are consistent with the known functions
of TARG1 in mono-ADP ribosylation hydrolysis, explaining why many
TARG1-interacting proteins are those with known ADP-ribosylation sites.
Visualizing the enrichment results for the set “PXD028902_hs_ADPribosylation_substrates”
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>F) reveals
that most matched proteins have low ranks (positive fold changes).
The matched significant proteins with the lowest <italic>p</italic>-values include ribosomal proteins, RNA helicases and a DNA topoisomerase
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>G). Interestingly,
the TARG1 interactome was previously shown to be highly enriched for
RNA metabolic processes.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Additionally,
PARP-1-mediated ADP-ribosylation of the RNA helicase DDX21 was shown
to promote ribosomal DNA (rDNA) transcription.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p>
      <p>Altogether, these findings illustrate the links between
ribosomal
proteins, RNA metabolism, and ADP-ribosylation through the TARG1 interactome.
Combining TeaProt with urPTMdb confidently identified alterations
in proteins known to be ADP-ribosylated in this dataset, implicating
this PTM in several cellular functions.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Discussion</title>
    <p>In
summary, we present urPTMdb and TeaProt for a novel and easy-to-use
online proteomics/transcriptomics analysis pipeline featuring novel
underrepresented gene sets to allow the discovery of downstream cellular
processes, upstream transcriptional regulation, and classes of PTMs
potentially regulated by a users’ intervention. The case studies
presented in this study highlight the application of these tools in
gaining understanding of the biological alterations and the power
of including underrepresented PTMs as a novel analysis. A potential
limitation of urPTMdb is that PTM substrates are reported at the protein
level, rather than for individual amino acid residues. Performing
PTM gene set enrichments at the protein level makes it difficult to
detect modifications of which its substrates are proteins with stable
abundances regardless of the treatment. Performing residue level analyses
could provide further insights into the association between altered
protein abundances and a particular site, or even multiple sites on
the same protein. Residue level analyses can be performed by PTM signature
enrichment analysis (PTM-SEA) using the PTM signatures database (PTMsigDB),
although updated gene set collections are required to include other
PTMs besides phosphorylation.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Further
improvements can be made to urPTMdb as new experimental underrepresented
PTM data are published, including the addition of novel PTMs and the
generation of consensus gene sets summarizing all studies related
to a PTM. We hope that urPTMdb will allow researchers to identify
currently underrepresented PTM alterations in their datasets, driving
future research into these exciting new fields.</p>
  </sec>
</body>
<back>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jproteome.2c00048?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jproteome.2c00048</ext-link>.<list id="silist" list-type="simple"><list-item><p>Table S1: Details
of the studies included in urPTMdb
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_002.xlsx">XLSX</ext-link>)</p></list-item><list-item><p>Table
S2: Contingency table of subcellular localization
analysis related to case study 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_003.xlsx">XLSX</ext-link>)</p></list-item><list-item><p>Table S3: Contingency table of subcellular
localization
analysis related to case study 2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.2c00048/suppl_file/pr2c00048_si_004.xlsx">XLSX</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile2">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_si_002.xlsx">
        <caption>
          <p>pr2c00048_si_002.xlsx</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="sifile3">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_si_003.xlsx">
        <caption>
          <p>pr2c00048_si_003.xlsx</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="sifile4">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr2c00048_si_004.xlsx">
        <caption>
          <p>pr2c00048_si_004.xlsx</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-2">
    <title>Author Contributions</title>
    <p>TeaProt was
developed by J.M. and R.Y. urPTMdb was developed by J.M. The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p>
  </notes>
  <notes notes-type="funding-statement" id="notes-3">
    <p>This work was
funded by an Australian National Health and Medical Research Council
Ideas Grant [Grant Number APP1184363]. B.L.P. is supported by the
University of Melbourne Driving Research Momentum program.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d7e608-autogenerated">
    <p>The authors declare no
competing financial interest.</p>
  </notes>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>PTM</term>
        <def>
          <p>post-translational modification</p>
        </def>
      </def-item>
      <def-item>
        <term>Kcr</term>
        <def>
          <p>lysine crotonylation</p>
        </def>
      </def-item>
      <def-item>
        <term>Ksu</term>
        <def>
          <p>lysine succinylation</p>
        </def>
      </def-item>
      <def-item>
        <term>Khib</term>
        <def>
          <p>lysine 2-hydroxyisobutyrylation</p>
        </def>
      </def-item>
      <def-item>
        <term>Kglu</term>
        <def>
          <p>lysine glutarylation.</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Subramanian</surname><given-names>A.</given-names></name>; <name><surname>Tamayo</surname><given-names>P.</given-names></name>; <name><surname>Mootha</surname><given-names>V. K.</given-names></name>; <name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>Ebert</surname><given-names>B. L.</given-names></name>; <name><surname>Gillette</surname><given-names>M. A.</given-names></name>; <name><surname>Paulovich</surname><given-names>A.</given-names></name>; <name><surname>Pomeroy</surname><given-names>S. L.</given-names></name>; <name><surname>Golub</surname><given-names>T. R.</given-names></name>; <name><surname>Lander</surname><given-names>E. S.</given-names></name>; <name><surname>Mesirov</surname><given-names>J. P.</given-names></name><article-title>Gene set
enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression profiles</article-title>. <source>Proc. Natl. Acad. Sci.
U.S.A.</source><year>2005</year>, <volume>102</volume> (<issue>43</issue>), <fpage>15545</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Krug</surname><given-names>K.</given-names></name>; <name><surname>Mertins</surname><given-names>P.</given-names></name>; <name><surname>Zhang</surname><given-names>B.</given-names></name>; <name><surname>Hornbeck</surname><given-names>P.</given-names></name>; <name><surname>Raju</surname><given-names>R.</given-names></name>; <name><surname>Ahmad</surname><given-names>R.</given-names></name>; <name><surname>Szucs</surname><given-names>M.</given-names></name>; <name><surname>Mundt</surname><given-names>F.</given-names></name>; <name><surname>Forestier</surname><given-names>D.</given-names></name>; <name><surname>Jane-Valbuena</surname><given-names>J.</given-names></name>; <name><surname>Keshishian</surname><given-names>H.</given-names></name>; <name><surname>Gillette</surname><given-names>M. A.</given-names></name>; <name><surname>Tamayo</surname><given-names>P.</given-names></name>; <name><surname>Mesirov</surname><given-names>J. P.</given-names></name>; <name><surname>Jaffe</surname><given-names>J. D.</given-names></name>; <name><surname>Carr</surname><given-names>S. A.</given-names></name>; <name><surname>Mani</surname><given-names>D. R.</given-names></name><article-title>A Curated
Resource for Phosphosite-specific Signature Analysis</article-title>. <source>Molecular &amp; cellular proteomics : MCP</source><year>2019</year>, <volume>18</volume> (<issue>3</issue>), <fpage>576</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.TIR118.000943</pub-id>.<pub-id pub-id-type="pmid">30563849</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Mohamed</surname><given-names>A.</given-names></name>; <name><surname>Molendijk</surname><given-names>J.</given-names></name>; <name><surname>Hill</surname><given-names>M. M.</given-names></name><article-title>lipidr: A Software Tool for Data
Mining and Analysis of Lipidomics Datasets</article-title>. <source>J. Proteome Res.</source><year>2020</year>, <volume>19</volume> (<issue>7</issue>), <fpage>2890</fpage>–<lpage>2897</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00082</pub-id>.<pub-id pub-id-type="pmid">32168452</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Maleki</surname><given-names>F.</given-names></name>; <name><surname>Ovens</surname><given-names>K.</given-names></name>; <name><surname>Hogan</surname><given-names>D. J.</given-names></name>; <name><surname>Kusalik</surname><given-names>A. J.</given-names></name><article-title>Gene Set Analysis:
Challenges, Opportunities, and Future Research</article-title>. <source>Front. Genet.</source><year>2020</year>, <volume>11</volume>, <fpage>654</fpage><pub-id pub-id-type="doi">10.3389/fgene.2020.00654</pub-id>.<pub-id pub-id-type="pmid">32695141</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Zolg</surname><given-names>D. P.</given-names></name>; <name><surname>Wilhelm</surname><given-names>M.</given-names></name>; <name><surname>Schmidt</surname><given-names>T.</given-names></name>; <name><surname>Médard</surname><given-names>G.</given-names></name>; <name><surname>Zerweck</surname><given-names>J.</given-names></name>; <name><surname>Knaute</surname><given-names>T.</given-names></name>; <name><surname>Wenschuh</surname><given-names>H.</given-names></name>; <name><surname>Reimer</surname><given-names>U.</given-names></name>; <name><surname>Schnatbaum</surname><given-names>K.</given-names></name>; <name><surname>Kuster</surname><given-names>B.</given-names></name><article-title>ProteomeTools: Systematic
Characterization
of 21 Post-translational Protein Modifications by Liquid Chromatography
Tandem Mass Spectrometry (LC-MS/MS) Using Synthetic Peptides</article-title>. <source>Molecular &amp; cellular proteomics : MCP</source><year>2018</year>, <volume>17</volume> (<issue>9</issue>), <fpage>1850</fpage>–<lpage>1863</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.TIR118.000783</pub-id>.<pub-id pub-id-type="pmid">29848782</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>S. N.</given-names></name>; <name><surname>Su</surname><given-names>Y. P.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Agama</surname><given-names>K.</given-names></name>; <name><surname>Saha</surname><given-names>S.</given-names></name>; <name><surname>Jenkins</surname><given-names>L. M.</given-names></name>; <name><surname>Pascal</surname><given-names>J. M.</given-names></name>; <name><surname>Pommier</surname><given-names>Y.</given-names></name><article-title>PARylation prevents
the proteasomal degradation of
topoisomerase I DNA-protein crosslinks and induces their deubiquitylation</article-title>. <source>Nat. Commun.</source><year>2021</year>, <volume>12</volume> (<issue>1</issue>), <fpage>5010</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-25252-9</pub-id>.<pub-id pub-id-type="pmid">34408146</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Gaffney</surname><given-names>D. O.</given-names></name>; <name><surname>Jennings</surname><given-names>E. Q.</given-names></name>; <name><surname>Anderson</surname><given-names>C. C.</given-names></name>; <name><surname>Marentette</surname><given-names>J. O.</given-names></name>; <name><surname>Shi</surname><given-names>T.</given-names></name>; <name><surname>Schou Oxvig</surname><given-names>A. M.</given-names></name>; <name><surname>Streeter</surname><given-names>M. D.</given-names></name>; <name><surname>Johannsen</surname><given-names>M.</given-names></name>; <name><surname>Spiegel</surname><given-names>D. A.</given-names></name>; <name><surname>Chapman</surname><given-names>E.</given-names></name>; <name><surname>Roede</surname><given-names>J. R.</given-names></name>; <name><surname>Galligan</surname><given-names>J. J.</given-names></name><article-title>Non-enzymatic
Lysine Lactoylation of Glycolytic Enzymes</article-title>. <source>Cell
Chem. Biol.</source><year>2020</year>, <volume>27</volume> (<issue>2</issue>), <fpage>206</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2019.11.005</pub-id>.<pub-id pub-id-type="pmid">31767537</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Keenan</surname><given-names>A. B.</given-names></name>; <name><surname>Torre</surname><given-names>D.</given-names></name>; <name><surname>Lachmann</surname><given-names>A.</given-names></name>; <name><surname>Leong</surname><given-names>A. K.</given-names></name>; <name><surname>Wojciechowicz</surname><given-names>M. L.</given-names></name>; <name><surname>Utti</surname><given-names>V.</given-names></name>; <name><surname>Jagodnik</surname><given-names>K. M.</given-names></name>; <name><surname>Kropiwnicki</surname><given-names>E.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Ma’ayan</surname><given-names>A.</given-names></name><article-title>ChEA3: transcription
factor enrichment
analysis by orthogonal omics integration</article-title>. <source>Nucleic
acids research</source><year>2019</year>, <volume>47</volume> (<issue>W1</issue>), <fpage>W212</fpage>–<lpage>w224</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz446</pub-id>.<pub-id pub-id-type="pmid">31114921</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Perez-Riverol</surname><given-names>Y.</given-names></name>; <name><surname>Csordas</surname><given-names>A.</given-names></name>; <name><surname>Bai</surname><given-names>J.</given-names></name>; <name><surname>Bernal-Llinares</surname><given-names>M.</given-names></name>; <name><surname>Hewapathirana</surname><given-names>S.</given-names></name>; <name><surname>Kundu</surname><given-names>D. J.</given-names></name>; <name><surname>Inuganti</surname><given-names>A.</given-names></name>; <name><surname>Griss</surname><given-names>J.</given-names></name>; <name><surname>Mayer</surname><given-names>G.</given-names></name>; <name><surname>Eisenacher</surname><given-names>M.</given-names></name>; <name><surname>Pérez</surname><given-names>E.</given-names></name>; <name><surname>Uszkoreit</surname><given-names>J.</given-names></name>; <name><surname>Pfeuffer</surname><given-names>J.</given-names></name>; <name><surname>Sachsenberg</surname><given-names>T.</given-names></name>; <name><surname>Yilmaz</surname><given-names>S.</given-names></name>; <name><surname>Tiwary</surname><given-names>S.</given-names></name>; <name><surname>Cox</surname><given-names>J.</given-names></name>; <name><surname>Audain</surname><given-names>E.</given-names></name>; <name><surname>Walzer</surname><given-names>M.</given-names></name>; <name><surname>Jarnuczak</surname><given-names>A. F.</given-names></name>; <name><surname>Ternent</surname><given-names>T.</given-names></name>; <name><surname>Brazma</surname><given-names>A.</given-names></name>; <name><surname>Vizcaíno</surname><given-names>J. A.</given-names></name><article-title>The PRIDE database and related tools and resources
in 2019: improving support for quantification data</article-title>. <source>Nucleic acids research</source><year>2019</year>, <volume>47</volume> (<issue>D1</issue>), <fpage>D442</fpage>–<lpage>d450</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1106</pub-id>.<pub-id pub-id-type="pmid">30395289</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Thul</surname><given-names>P. J.</given-names></name>; <name><surname>Åkesson</surname><given-names>L.</given-names></name>; <name><surname>Wiking</surname><given-names>M.</given-names></name>; <name><surname>Mahdessian</surname><given-names>D.</given-names></name>; <name><surname>Geladaki</surname><given-names>A.</given-names></name>; <name><surname>Ait Blal</surname><given-names>H.</given-names></name>; <name><surname>Alm</surname><given-names>T.</given-names></name>; <name><surname>Asplund</surname><given-names>A.</given-names></name>; <name><surname>Björk</surname><given-names>L.</given-names></name>; <name><surname>Breckels</surname><given-names>L. M.</given-names></name>; <name><surname>Bäckström</surname><given-names>A.</given-names></name>; <name><surname>Danielsson</surname><given-names>F.</given-names></name>; <name><surname>Fagerberg</surname><given-names>L.</given-names></name>; <name><surname>Fall</surname><given-names>J.</given-names></name>; <name><surname>Gatto</surname><given-names>L.</given-names></name>; <name><surname>Gnann</surname><given-names>C.</given-names></name>; <name><surname>Hober</surname><given-names>S.</given-names></name>; <name><surname>Hjelmare</surname><given-names>M.</given-names></name>; <name><surname>Johansson</surname><given-names>F.</given-names></name>; <name><surname>Lee</surname><given-names>S.</given-names></name>; <name><surname>Lindskog</surname><given-names>C.</given-names></name>; <name><surname>Mulder</surname><given-names>J.</given-names></name>; <name><surname>Mulvey</surname><given-names>C. M.</given-names></name>; <name><surname>Nilsson</surname><given-names>P.</given-names></name>; <name><surname>Oksvold</surname><given-names>P.</given-names></name>; <name><surname>Rockberg</surname><given-names>J.</given-names></name>; <name><surname>Schutten</surname><given-names>R.</given-names></name>; <name><surname>Schwenk</surname><given-names>J. M.</given-names></name>; <name><surname>Sivertsson</surname><given-names>Å.</given-names></name>; <name><surname>Sjöstedt</surname><given-names>E.</given-names></name>; <name><surname>Skogs</surname><given-names>M.</given-names></name>; <name><surname>Stadler</surname><given-names>C.</given-names></name>; <name><surname>Sullivan</surname><given-names>D. P.</given-names></name>; <name><surname>Tegel</surname><given-names>H.</given-names></name>; <name><surname>Winsnes</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Zwahlen</surname><given-names>M.</given-names></name>; <name><surname>Mardinoglu</surname><given-names>A.</given-names></name>; <name><surname>Pontén</surname><given-names>F.</given-names></name>; <name><surname>von Feilitzen</surname><given-names>K.</given-names></name>; <name><surname>Lilley</surname><given-names>K. S.</given-names></name>; <name><surname>Uhlén</surname><given-names>M.</given-names></name>; <name><surname>Lundberg</surname><given-names>E.</given-names></name><article-title>A subcellular map of the human proteome</article-title>. <source>Science</source><year>2017</year>, <pub-id pub-id-type="doi">10.1126/science.aal3321</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Molendijk</surname><given-names>J.</given-names></name>; <name><surname>Seldin</surname><given-names>M. M.</given-names></name>; <name><surname>Parker</surname><given-names>B. L.</given-names></name><article-title>CoffeeProt: an online tool for correlation
and functional enrichment of systems genetics data</article-title>. <source>Nucleic acids research</source><year>2021</year>, <volume>49</volume> (<issue>W1</issue>), <fpage>W104</fpage>–<lpage>w113</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab352</pub-id>.<pub-id pub-id-type="pmid">33978718</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Dickinson</surname><given-names>M. E.</given-names></name>; <name><surname>Flenniken</surname><given-names>A. M.</given-names></name>; <name><surname>Ji</surname><given-names>X.</given-names></name>; <name><surname>Teboul</surname><given-names>L.</given-names></name>; <name><surname>Wong</surname><given-names>M. D.</given-names></name>; <name><surname>White</surname><given-names>J. K.</given-names></name>; <name><surname>Meehan</surname><given-names>T. F.</given-names></name>; <name><surname>Weninger</surname><given-names>W. J.</given-names></name>; <name><surname>Westerberg</surname><given-names>H.</given-names></name>; <name><surname>Adissu</surname><given-names>H.</given-names></name>; <name><surname>Baker</surname><given-names>C. N.</given-names></name>; <name><surname>Bower</surname><given-names>L.</given-names></name>; <name><surname>Brown</surname><given-names>J. M.</given-names></name>; <name><surname>Caddle</surname><given-names>L. B.</given-names></name>; <name><surname>Chiani</surname><given-names>F.</given-names></name>; <name><surname>Clary</surname><given-names>D.</given-names></name>; <name><surname>Cleak</surname><given-names>J.</given-names></name>; <name><surname>Daly</surname><given-names>M. J.</given-names></name>; <name><surname>Denegre</surname><given-names>J. M.</given-names></name>; <name><surname>Doe</surname><given-names>B.</given-names></name>; <name><surname>Dolan</surname><given-names>M. E.</given-names></name>; <name><surname>Edie</surname><given-names>S. M.</given-names></name>; <name><surname>Fuchs</surname><given-names>H.</given-names></name>; <name><surname>Gailus-Durner</surname><given-names>V.</given-names></name>; <name><surname>Galli</surname><given-names>A.</given-names></name>; <name><surname>Gambadoro</surname><given-names>A.</given-names></name>; <name><surname>Gallegos</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>S.</given-names></name>; <name><surname>Horner</surname><given-names>N. R.</given-names></name>; <name><surname>Hsu</surname><given-names>C. W.</given-names></name>; <name><surname>Johnson</surname><given-names>S. J.</given-names></name>; <name><surname>Kalaga</surname><given-names>S.</given-names></name>; <name><surname>Keith</surname><given-names>L. C.</given-names></name>; <name><surname>Lanoue</surname><given-names>L.</given-names></name>; <name><surname>Lawson</surname><given-names>T. N.</given-names></name>; <name><surname>Lek</surname><given-names>M.</given-names></name>; <name><surname>Mark</surname><given-names>M.</given-names></name>; <name><surname>Marschall</surname><given-names>S.</given-names></name>; <name><surname>Mason</surname><given-names>J.</given-names></name>; <name><surname>McElwee</surname><given-names>M. L.</given-names></name>; <name><surname>Newbigging</surname><given-names>S.</given-names></name>; <name><surname>Nutter</surname><given-names>L. M.</given-names></name>; <name><surname>Peterson</surname><given-names>K. A.</given-names></name>; <name><surname>Ramirez-Solis</surname><given-names>R.</given-names></name>; <name><surname>Rowland</surname><given-names>D. J.</given-names></name>; <name><surname>Ryder</surname><given-names>E.</given-names></name>; <name><surname>Samocha</surname><given-names>K. E.</given-names></name>; <name><surname>Seavitt</surname><given-names>J. R.</given-names></name>; <name><surname>Selloum</surname><given-names>M.</given-names></name>; <name><surname>Szoke-Kovacs</surname><given-names>Z.</given-names></name>; <name><surname>Tamura</surname><given-names>M.</given-names></name>; <name><surname>Trainor</surname><given-names>A. G.</given-names></name>; <name><surname>Tudose</surname><given-names>I.</given-names></name>; <name><surname>Wakana</surname><given-names>S.</given-names></name>; <name><surname>Warren</surname><given-names>J.</given-names></name>; <name><surname>Wendling</surname><given-names>O.</given-names></name>; <name><surname>West</surname><given-names>D. B.</given-names></name>; <name><surname>Wong</surname><given-names>L.</given-names></name>; <name><surname>Yoshiki</surname><given-names>A.</given-names></name>; <name><surname>MacArthur</surname><given-names>D. G.</given-names></name>; <name><surname>Tocchini-Valentini</surname><given-names>G. P.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name>; <name><surname>Flicek</surname><given-names>P.</given-names></name>; <name><surname>Bradley</surname><given-names>A.</given-names></name>; <name><surname>Skarnes</surname><given-names>W. C.</given-names></name>; <name><surname>Justice</surname><given-names>M. J.</given-names></name>; <name><surname>Parkinson</surname><given-names>H. E.</given-names></name>; <name><surname>Moore</surname><given-names>M.</given-names></name>; <name><surname>Wells</surname><given-names>S.</given-names></name>; <name><surname>Braun</surname><given-names>R. E.</given-names></name>; <name><surname>Svenson</surname><given-names>K. L.</given-names></name>; <name><surname>de Angelis</surname><given-names>M. H.</given-names></name>; <name><surname>Herault</surname><given-names>Y.</given-names></name>; <name><surname>Mohun</surname><given-names>T.</given-names></name>; <name><surname>Mallon</surname><given-names>A. M.</given-names></name>; <name><surname>Henkelman</surname><given-names>R. M.</given-names></name>; <name><surname>Brown</surname><given-names>S. D.</given-names></name>; <name><surname>Adams</surname><given-names>D. J.</given-names></name>; <name><surname>Lloyd</surname><given-names>K. C.</given-names></name>; <name><surname>McKerlie</surname><given-names>C.</given-names></name>; <name><surname>Beaudet</surname><given-names>A. L.</given-names></name>; <name><surname>Bućan</surname><given-names>M.</given-names></name>; <name><surname>Murray</surname><given-names>S. A.</given-names></name><article-title>High-throughput discovery of novel developmental phenotypes</article-title>. <source>Nature</source><year>2016</year>, <volume>537</volume> (<issue>7621</issue>), <fpage>508</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/nature19356</pub-id>.<pub-id pub-id-type="pmid">27626380</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Piñero</surname><given-names>J.</given-names></name>; <name><surname>Ramírez-Anguita</surname><given-names>J. M.</given-names></name>; <name><surname>Saüch-Pitarch</surname><given-names>J.</given-names></name>; <name><surname>Ronzano</surname><given-names>F.</given-names></name>; <name><surname>Centeno</surname><given-names>E.</given-names></name>; <name><surname>Sanz</surname><given-names>F.</given-names></name>; <name><surname>Furlong</surname><given-names>L. I.</given-names></name><article-title>The DisGeNET
knowledge platform for disease genomics: 2019 update</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume> (<issue>D1</issue>), <fpage>D845</fpage>–<lpage>D855</lpage>.<pub-id pub-id-type="pmid">31680165</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Chang</surname><given-names>A.</given-names></name>; <name><surname>Jeske</surname><given-names>L.</given-names></name>; <name><surname>Ulbrich</surname><given-names>S.</given-names></name>; <name><surname>Hofmann</surname><given-names>J.</given-names></name>; <name><surname>Koblitz</surname><given-names>J.</given-names></name>; <name><surname>Schomburg</surname><given-names>I.</given-names></name>; <name><surname>Neumann-Schaal</surname><given-names>M.</given-names></name>; <name><surname>Jahn</surname><given-names>D.</given-names></name>; <name><surname>Schomburg</surname><given-names>D.</given-names></name><article-title>BRENDA, the
ELIXIR core data resource in 2021: new developments and updates</article-title>. <source>Nucleic acids research</source><year>2021</year>, <volume>49</volume> (<issue>D1</issue>), <fpage>D498</fpage>–<lpage>d508</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1025</pub-id>.<pub-id pub-id-type="pmid">33211880</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Freshour</surname><given-names>S. L.</given-names></name>; <name><surname>Kiwala</surname><given-names>S.</given-names></name>; <name><surname>Cotto</surname><given-names>K. C.</given-names></name>; <name><surname>Coffman</surname><given-names>A. C.</given-names></name>; <name><surname>McMichael</surname><given-names>J. F.</given-names></name>; <name><surname>Song</surname><given-names>J. J.</given-names></name>; <name><surname>Griffith</surname><given-names>M.</given-names></name>; <name><surname>Griffith</surname><given-names>O. L.</given-names></name>; <name><surname>Wagner</surname><given-names>A. H.</given-names></name><article-title>Integration
of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource
efforts</article-title>. <source>Nucleic acids research</source><year>2021</year>, <volume>49</volume> (<issue>D1</issue>), <fpage>D1144</fpage>–<lpage>d1151</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1084</pub-id>.<pub-id pub-id-type="pmid">33237278</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="undeclared" id="cit16"><person-group><name><surname>Korotkevich</surname><given-names>G.</given-names></name>; <name><surname>Sukhov</surname><given-names>V.</given-names></name>; <name><surname>Budin</surname><given-names>N.</given-names></name>; <name><surname>Shpak</surname><given-names>B.</given-names></name>; <name><surname>Artyomov</surname><given-names>M. N.</given-names></name>; <name><surname>Sergushichev</surname><given-names>A.</given-names></name></person-group><article-title>Fast
gene set enrichment analysis</article-title>. <source>bioRxiv</source>, February 1, <year>2021</year>. <pub-id pub-id-type="doi">10.1101/060012</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Dutt</surname><given-names>M.</given-names></name>; <name><surname>Ng</surname><given-names>Y. K.</given-names></name>; <name><surname>Molendijk</surname><given-names>J.</given-names></name>; <name><surname>Karimkhanloo</surname><given-names>H.</given-names></name>; <name><surname>Liao</surname><given-names>L.</given-names></name>; <name><surname>Blazev</surname><given-names>R.</given-names></name>; <name><surname>Montgomery</surname><given-names>M. K.</given-names></name>; <name><surname>Watt</surname><given-names>M. J.</given-names></name>; <name><surname>Parker</surname><given-names>B. L.</given-names></name><article-title>Western Diet Induced Remodelling
of the Tongue Proteome</article-title>. <source>Proteomes</source><year>2021</year>, <volume>9</volume> (<issue>2</issue>), <fpage>22</fpage><pub-id pub-id-type="doi">10.3390/proteomes9020022</pub-id>.<pub-id pub-id-type="pmid">34066295</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Ægidius</surname><given-names>H. M.</given-names></name>; <name><surname>Veidal</surname><given-names>S. S.</given-names></name>; <name><surname>Feigh</surname><given-names>M.</given-names></name>; <name><surname>Hallenborg</surname><given-names>P.</given-names></name>; <name><surname>Puglia</surname><given-names>M.</given-names></name>; <name><surname>Pers</surname><given-names>T. H.</given-names></name>; <name><surname>Vrang</surname><given-names>N.</given-names></name>; <name><surname>Jelsing</surname><given-names>J.</given-names></name>; <name><surname>Kornum</surname><given-names>B. R.</given-names></name>; <name><surname>Blagoev</surname><given-names>B.</given-names></name>; <name><surname>Rigbolt</surname><given-names>K. T. G.</given-names></name><article-title>Multi-omics
characterization
of a diet-induced obese model of non-alcoholic steatohepatitis</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>1148</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-58059-7</pub-id>.<pub-id pub-id-type="pmid">31980690</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Lindeque</surname><given-names>J. Z.</given-names></name>; <name><surname>Jansen van Rensburg</surname><given-names>P.
J.</given-names></name>; <name><surname>Louw</surname><given-names>R.</given-names></name>; <name><surname>van der
Westhuizen</surname><given-names>F. H.</given-names></name>; <name><surname>Florit</surname><given-names>S.</given-names></name>; <name><surname>Ramírez</surname><given-names>L.</given-names></name>; <name><surname>Giralt</surname><given-names>M.</given-names></name>; <name><surname>Hidalgo</surname><given-names>J.</given-names></name><article-title>Obesity and metabolomics: metallothioneins
protect against high-fat diet-induced consequences in metallothionein
knockout mice</article-title>. <source>OMICS: J. Integr. Biol.</source><year>2015</year>, <volume>19</volume> (<issue>2</issue>), <fpage>92</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2014.0087</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Sundekilde</surname><given-names>U. K.</given-names></name>; <name><surname>Yde</surname><given-names>C. C.</given-names></name>; <name><surname>Honore</surname><given-names>A. H.</given-names></name>; <name><surname>Caverly Rae</surname><given-names>J. M.</given-names></name>; <name><surname>Burns</surname><given-names>F. R.</given-names></name>; <name><surname>Mukerji</surname><given-names>P.</given-names></name>; <name><surname>Mawn</surname><given-names>M. P.</given-names></name>; <name><surname>Stenman</surname><given-names>L.</given-names></name>; <name><surname>Dragan</surname><given-names>Y.</given-names></name>; <name><surname>Glover</surname><given-names>K.</given-names></name>; <name><surname>Jensen</surname><given-names>H. M.</given-names></name><article-title>An Integrated Multi-Omics
Analysis Defines Key Pathway Alterations in a Diet-Induced Obesity
Mouse Model</article-title>. <source>Metabolites</source><year>2020</year>, <volume>10</volume> (<issue>3</issue>), <fpage>80</fpage><pub-id pub-id-type="doi">10.3390/metabo10030080</pub-id>.<pub-id pub-id-type="pmid">32106514</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Svahn</surname><given-names>S. L.</given-names></name>; <name><surname>Pattanaik</surname><given-names>B.</given-names></name>; <name><surname>Grahnemo</surname><given-names>L.</given-names></name>; <name><surname>Gutierrez</surname><given-names>S.</given-names></name>; <name><surname>Nookaew</surname><given-names>I.</given-names></name>; <name><surname>Jansson</surname><given-names>J. O.</given-names></name>; <name><surname>Johansson</surname><given-names>M. E.</given-names></name><article-title>Spleen
proteomics data from high fat diet fed mice</article-title>. <source>Data in brief</source><year>2020</year>, <volume>32</volume>, <fpage>106110</fpage><pub-id pub-id-type="doi">10.1016/j.dib.2020.106110</pub-id>.<pub-id pub-id-type="pmid">32904176</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Brooks</surname><given-names>P. T.</given-names></name>; <name><surname>Munthe-Fog</surname><given-names>L.</given-names></name>; <name><surname>Rieneck</surname><given-names>K.</given-names></name>; <name><surname>Banch Clausen</surname><given-names>F.</given-names></name>; <name><surname>Rivera</surname><given-names>O. B.</given-names></name>; <name><surname>Kannik Haastrup</surname><given-names>E.</given-names></name>; <name><surname>Fischer-Nielsen</surname><given-names>A.</given-names></name>; <name><surname>Svalgaard</surname><given-names>J. D.</given-names></name><article-title>Application of a deep learning-based image analysis
and live-cell imaging system for quantifying adipogenic differentiation
kinetics of adipose-derived stem/stromal cells</article-title>. <source>Adipocyte</source><year>2021</year>, <volume>10</volume> (<issue>1</issue>), <fpage>621</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1080/21623945.2021.2000696</pub-id>.<pub-id pub-id-type="pmid">34747303</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Wagner</surname><given-names>G. R.</given-names></name>; <name><surname>Bhatt</surname><given-names>D. P.</given-names></name>; <name><surname>O’Connell</surname><given-names>T. M.</given-names></name>; <name><surname>Thompson</surname><given-names>J. W.</given-names></name>; <name><surname>Dubois</surname><given-names>L. G.</given-names></name>; <name><surname>Backos</surname><given-names>D. S.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Mitchell</surname><given-names>G. A.</given-names></name>; <name><surname>Ilkayeva</surname><given-names>O. R.</given-names></name>; <name><surname>Stevens</surname><given-names>R. D.</given-names></name>; <name><surname>Grimsrud</surname><given-names>P. A.</given-names></name>; <name><surname>Hirschey</surname><given-names>M. D.</given-names></name><article-title>A Class of Reactive
Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation</article-title>. <source>Cell Metabol.</source><year>2017</year>, <volume>25</volume> (<issue>4</issue>), <fpage>823</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.006</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Bütepage</surname><given-names>M.</given-names></name>; <name><surname>Preisinger</surname><given-names>C.</given-names></name>; <name><surname>von Kriegsheim</surname><given-names>A.</given-names></name>; <name><surname>Scheufen</surname><given-names>A.</given-names></name>; <name><surname>Lausberg</surname><given-names>E.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Kappes</surname><given-names>F.</given-names></name>; <name><surname>Feederle</surname><given-names>R.</given-names></name>; <name><surname>Ernst</surname><given-names>S.</given-names></name>; <name><surname>Eckei</surname><given-names>L.</given-names></name>; <name><surname>Krieg</surname><given-names>S.</given-names></name>; <name><surname>Müller-Newen</surname><given-names>G.</given-names></name>; <name><surname>Rossetti</surname><given-names>G.</given-names></name>; <name><surname>Feijs</surname><given-names>K. L. H.</given-names></name>; <name><surname>Verheugd</surname><given-names>P.</given-names></name>; <name><surname>Lüscher</surname><given-names>B.</given-names></name><article-title>Nucleolar-nucleoplasmic shuttling
of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation
and by nucleolar transcription</article-title>. <source>Sci. Rep.</source><year>2018</year>, <volume>8</volume> (<issue>1</issue>), <fpage>6748</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-25137-w</pub-id>.<pub-id pub-id-type="pmid">29712969</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Žaja</surname><given-names>R.</given-names></name>; <name><surname>Aydin</surname><given-names>G.</given-names></name>; <name><surname>Lippok</surname><given-names>B. E.</given-names></name>; <name><surname>Feederle</surname><given-names>R.</given-names></name>; <name><surname>Lüscher</surname><given-names>B.</given-names></name>; <name><surname>Feijs</surname><given-names>K. L. H.</given-names></name><article-title>Comparative analysis
of MACROD1, MACROD2 and TARG1
expression, localisation and interactome</article-title>. <source>Sci.
Rep.</source><year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>8286</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-64623-y</pub-id>.<pub-id pub-id-type="pmid">32427867</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Challa</surname><given-names>S.</given-names></name>; <name><surname>Khulpateea</surname><given-names>B. R.</given-names></name>; <name><surname>Nandu</surname><given-names>T.</given-names></name>; <name><surname>Camacho</surname><given-names>C. V.</given-names></name>; <name><surname>Ryu</surname><given-names>K. W.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Lea</surname><given-names>J. S.</given-names></name>; <name><surname>Kraus</surname><given-names>W. L.</given-names></name><article-title>Ribosome
ADP-ribosylation inhibits translation and maintains proteostasis in
cancers</article-title>. <source>Cell</source><year>2021</year>, <volume>184</volume> (<issue>17</issue>), <fpage>4531</fpage>–<lpage>4546</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.07.005</pub-id>.<pub-id pub-id-type="pmid">34314702</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Kim</surname><given-names>D. S.</given-names></name>; <name><surname>Camacho</surname><given-names>C. V.</given-names></name>; <name><surname>Nagari</surname><given-names>A.</given-names></name>; <name><surname>Malladi</surname><given-names>V. S.</given-names></name>; <name><surname>Challa</surname><given-names>S.</given-names></name>; <name><surname>Kraus</surname><given-names>W. L.</given-names></name><article-title>Activation of PARP-1
by snoRNAs Controls Ribosome Biogenesis
and Cell Growth via the RNA Helicase DDX21</article-title>. <source>Mol. Cell</source><year>2019</year>, <volume>75</volume> (<issue>6</issue>), <fpage>1270</fpage>–<lpage>1285</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2019.06.020</pub-id>.<pub-id pub-id-type="pmid">31351877</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
